Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
BMJ. 2018 Nov 14;363:k3532. doi: 10.1136/bmj.k3532.
In pharmacoepidemiology, routinely collected data from electronic health records (including primary care databases, registries, and administrative healthcare claims) are a resource for research evaluating the real world effectiveness and safety of medicines. Currently available guidelines for the reporting of research using non-randomised, routinely collected data—specifically the REporting of studies Conducted using Observational Routinely collected health Data (RECORD) and the Strengthening the Reporting of OBservational studies in Epidemiology (STROBE) statements—do not capture the complexity of pharmacoepidemiological research. We have therefore extended the RECORD statement to include reporting guidelines specific to pharmacoepidemiological research (RECORD-PE). This article includes the RECORD-PE checklist (also available on www.record-statement.org) and explains each checklist item with examples of good reporting. We anticipate that increasing use of the RECORD-PE guidelines by researchers and endorsement and adherence by journal editors will improve the standards of reporting of pharmacoepidemiological research undertaken using routinely collected data. This improved transparency will benefit the research community, patient care, and ultimately improve public health.
在药物流行病学中,电子健康记录(包括初级保健数据库、登记处和行政医疗保健索赔)中常规收集的数据是评估药物真实世界疗效和安全性的研究资源。目前,针对使用非随机、常规收集数据进行研究报告的指南——特别是使用观察性常规收集健康数据进行研究报告(RECORD)和加强观察性研究在流行病学中的报告(STROBE)声明——并没有捕捉到药物流行病学研究的复杂性。因此,我们扩展了 RECORD 声明,以包括针对药物流行病学研究的报告指南(RECORD-PE)。本文包括 RECORD-PE 清单(也可在 www.record-statement.org 上获得),并通过良好报告的示例解释了每个清单项目。我们预计,研究人员越来越多地使用 RECORD-PE 指南,以及期刊编辑的认可和遵守,将提高使用常规收集数据进行药物流行病学研究的报告标准。这种提高的透明度将使研究界、患者护理受益,并最终改善公共卫生。